127 related articles for article (PubMed ID: 12622261)
1. Meloxicam complexation with beta-cyclodextrin: influence on the anti-inflammatory and ulcerogenic activity.
Baboota S; Agarwal SP
Pharmazie; 2003 Jan; 58(1):73-4. PubMed ID: 12622261
[No Abstract] [Full Text] [Related]
2. Influence on analgesic activity and serum levels after meloxicam complexation with beta-cyclodextrin in mice and rats.
Janovský M; Dolezal T; Procháizková M; Slíva J; Krsiak M
Arzneimittelforschung; 2010; 60(6):320-3. PubMed ID: 20648921
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance.
Engelhardt G; Homma D; Schlegel K; Utzmann R; Schnitzler C
Inflamm Res; 1995 Oct; 44(10):423-33. PubMed ID: 8564518
[TBL] [Abstract][Full Text] [Related]
4. Analgesic, antiinflammatory, and ulcerogenic studies of meloxicam solid dispersion prepared with polyethylene glycol 6000.
Vijaya Kumar SG; Mishra DN
Methods Find Exp Clin Pharmacol; 2006 Sep; 28(7):419-22. PubMed ID: 17003846
[TBL] [Abstract][Full Text] [Related]
5. Investigations on analgesic, anti-inflammatory and ulcerogenic potential of meloxicam solid dispersion prepared with skimmed milk.
Mishra DN; Vijaya Kumar SG
Yakugaku Zasshi; 2006 Jul; 126(7):495-8. PubMed ID: 16819271
[TBL] [Abstract][Full Text] [Related]
6. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies.
Shende PK; Gaud RS; Bakal R; Patil D
Colloids Surf B Biointerfaces; 2015 Dec; 136():105-10. PubMed ID: 26364091
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2.
Engelhardt G
Br J Rheumatol; 1996 Apr; 35 Suppl 1():4-12. PubMed ID: 8630636
[TBL] [Abstract][Full Text] [Related]
8. [The new nonsteroidal anti-inflammatory preparation meloxicam in the treatment of rheumatoid arthritis].
Grishina EI
Lik Sprava; 1997; (2):19-25. PubMed ID: 9333474
[No Abstract] [Full Text] [Related]
9. Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary systems.
Naidu NB; Chowdary KP; Murthy KV; Satyanarayana V; Hayman AR; Becket G
J Pharm Biomed Anal; 2004 Apr; 35(1):75-86. PubMed ID: 15030882
[TBL] [Abstract][Full Text] [Related]
10. Meloxicam.
Fleischmann R; Iqbal I; Slobodin G
Expert Opin Pharmacother; 2002 Oct; 3(10):1501-12. PubMed ID: 12387696
[TBL] [Abstract][Full Text] [Related]
11. Preparation of meloxicam-β-cyclodextrin-polyethylene glycol 6000 ternary system: characterization, in vitro and in vivo bioavailability.
Radia O; Rogalska E; Moulay-Hassane G
Pharm Dev Technol; 2012; 17(5):632-7. PubMed ID: 21428700
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4'-isomer.
Pairet M; van Ryn J; Schierok H; Mauz A; Trummlitz G; Engelhardt G
Inflamm Res; 1998 Jun; 47(6):270-6. PubMed ID: 9683035
[TBL] [Abstract][Full Text] [Related]
13. Positively charged polymeric nanoparticles: application in improving therapeutic efficacy of meloxicam after oral administration.
Khachane P; Date AA; Nagarsenker MS
Pharmazie; 2011 May; 66(5):334-8. PubMed ID: 21699066
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo investigations on the binary meloxicam-mannitol system.
Nassab PR; Blazsó G; Nyári T; Falkay G; Szabó-Révész P
Pharmazie; 2008 Apr; 63(4):319-20. PubMed ID: 18468395
[TBL] [Abstract][Full Text] [Related]
15. Density functional calculations on meloxicam-beta-cyclodextrin inclusion complexes.
Snor W; Liedl E; Weiss-Greiler P; Viernstein H; Wolschann P
Int J Pharm; 2009 Nov; 381(2):146-52. PubMed ID: 19446616
[TBL] [Abstract][Full Text] [Related]
16. General pharmacology of meloxicam--Part I: Effects on CNS, gastric emptying, intestinal transport, water, electrolyte and creatinine excretion.
Engelhardt G; Homma D; Schlegel K; Schnitzler C; Utzmann R
Gen Pharmacol; 1996 Jun; 27(4):673-7. PubMed ID: 8853304
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy and intolerance of meloxicam in injection and tablet form].
Tiurin VP; Rakov AL
Voen Med Zh; 2003 Nov; 324(11):54-8. PubMed ID: 14725079
[No Abstract] [Full Text] [Related]
18. Nonsteroidal anti-inflammatory drugs induce hypermotilinemia and disturbance of interdigestive migrating contractions in instrumented dogs.
Narita T; Okabe N; Hane M; Yamamoto Y; Tani K; Naito Y; Hara S
J Vet Pharmacol Ther; 2006 Dec; 29(6):569-77. PubMed ID: 17083462
[TBL] [Abstract][Full Text] [Related]
19. Meloxicam-induced enteropathy of the small bowel.
Are C; Turagam M; Aucar JA; Greenberg E
CMAJ; 2011 Mar; 183(5):577-80. PubMed ID: 20974723
[No Abstract] [Full Text] [Related]
20. [Meloxicam].
Sternon J; Appelboom T
Rev Med Brux; 1998 Feb; 19(1):29-32. PubMed ID: 9553452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
